Phase II study of lapatinib in combination with vinorelbine in patients with HER2 positive recurrent or metastatic breast cancer: A multicentric Turkish Oncology Group (TOG) trial


Saip P., Eralp Y., Sen F., Karaca H., Ozkan M., Cetin B., ...Daha Fazla

BREAST, cilt.22, sa.5, ss.628-633, 2013 (SCI-Expanded) identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 22 Sayı: 5
  • Basım Tarihi: 2013
  • Doi Numarası: 10.1016/j.breast.2013.07.048
  • Dergi Adı: BREAST
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.628-633
  • Marmara Üniversitesi Adresli: Evet

Özet

Background: The aim of this explorative phase II study was to evaluate the activity and safety of lapatinib in combination with intravenous vinorelbine in women with HER2 positive metastatic or recurrent breast cancer.